About 40% of patients who received a combination of Bristol-Myers Squibb Co'...
- About 40% of patients who received a combination of Bristol-Myers Squibb Co’s immuno-oncology drugs Opdivo and Yervoy as an initial treatment for advanced non-small cell lung cancer were alive after two years, according to data presented at a medical meeting on Saturday.
Bristol-Myers also said an exploratory analysis of patients whose tumors had even lower levels of the protein also showed a roughly 40% survival rate after two years, compared with 23% for patients who received chemotherapy. Bristol-Myers released top-line results of part of the study in July, showing that Opdivo combined with chemotherapy failed to extend overall survival more than chemotherapy alone in advanced NSCLC. Keytruda plus chemotherapy has shown an ability to extend survival over chemotherapy alone in Merck-sponsored lung cancer trials.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Your Worst Dating Habit, According to Your Myers-Briggs TypeWe've got you pegged.
Read more »
European shares rise on trade-fueled optimism, London shinesEuropean shares rose on Friday, with London stocks outperforming due to a weaker...
Read more »
‘I’m A Male Breast Cancer Survivor—And, You Guys, Mammograms Are Weird’For Breast Cancer Awareness Month 2019, Aubrey Glencamp shares his experience being diagnosed with an aggressive form of the cancer in his 30s as a black man.
Read more »
Marijuana vape sales lag as lung illnesses rise in USVaping products, one of the fastest-growing segments of the legal marijuana industry, have taken a hit from consumers as public health experts scramble to determine what&39;s causing a mysterious and sometimes fatal lung disease among people who use e-cigarettes. Some vaped nicotine, but many reported
Read more »
CDC urges people to avoid vaping THC amid lung disease outbreakThe Centers for Disease Control and Prevention is urging people to stop vaping THC products as the death toll from a vaping-related lung disease rose again this week with no signs of abating.
Read more »